The southern Africa country has the world’s highest prevalence of HIV but the amount of lenacapavir reaching it is too small to reach all those at risk ...
A ground-breaking new drug to prevent HIV infection – the closest the world has to a vaccine – is being rolled out in some of ...
Over the past three decades, there have been amazing advances in treating and preventing HIV. Subscribe to our newsletter for the latest sci-tech news updates. It's now a manageable infection. A ...
The chemokine receptors CCR5 and CXCR4 are the two major coreceptors for HIV entry. Numerous efforts have been made to develop a new class of anti-HIV agents that target these coreceptors as an ...
SALT LAKE CITY — University of Utah biochemist Wesley Sundquist achieved yet another milestone last week when the Food and Drug Administration approved an antiviral drug for HIV prevention based on ...
The Food and Drug Administration has just approved a preventative HIV drug widely regarded as a breakthrough. On Wednesday afternoon, the FDA approved Gilead Sciences’ lenacapavir as a more convenient ...
Diabetes mellitus affects more than 10% of people with HIV, and its incidence is rising as the population ages, according to ...
Coinfection of HIV and HCV leads to worse outcomes, necessitating effective HCV treatment in this population. Direct-acting antivirals show over 95% efficacy, yet HCV clearance rates in coinfected ...
Diabetes mellitus affects more than 10% of people with HIV, and its incidence is rising as the population ages, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results